Reference : BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on ...

	Document type :	Scientific congresses and symposiums : Poster
	Discipline(s) :	Human health sciences : Pharmacy, pharmacology & toxicology
	To cite this reference:	http://hdl.handle.net/2268/68726

Title :	BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane A2 receptors
Language :	English
Author, co-author :	Hanson, Julien [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
	Rolin, S. [ > > ]
	De Leval, X. [ > > ]
	Neven, P. [ > > ]
	Masereel, B. [ > > ]
	Pirotte, Bernard [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
	Dogne, J. M. [ > > ]
Publication date :	Dec-2003
Peer reviewed :	Yes
Audience :	International
Event name :	45th ASH Annual Meeting
Event date :	6-9 décembre 2003
Event place (city) :	san Diego
Event country :	USA
Permalink :	http://hdl.handle.net/2268/68726

There is no file associated with this reference.

All documents in ORBi are protected by a user license.

 

© ULg Library Network |  Feedback |  ORBi legal notices

Dspace v1.5